+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Plasmid DNA Contract Manufacturing Market

  • PDF Icon

    Report

  • 200 Pages
  • May 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5968457
The global plasmid DNA contract manufacturing market accounted for USD 0.329 billion in 2023 and is expected to reach USD 2.29 billion by 2034 with a CAGR of 19.33% during the forecast period 2024-2034. The market will grow as a result of factors such as growing demand for nucleic acid vaccines and gene therapies, biotechnology advancements, an increased emphasis on research and development, outsourcing manufacturing needs, and an increase in partnerships and collaborations.

The creation of nucleic acid vaccines and gene treatments depends heavily on plasmid DNA. Nucleic acid vaccines have become an effective weapon in the fight against infectious diseases, while gene therapy provides potential new treatments for a variety of ailments. The market for plasmid DNA contract manufacturing is driven by the rising demand for these medicines due to the rising prevalence of chronic illnesses and the growing emphasis on personalized medicine. For instance, in October 2023, VGXI, Inc. and WuXi AppTec announced a partnership to provide integrated AAV (adeno-associated virus) vector and plasmid DNA production services, aiming to serve the expanding gene therapy market.

By application, the cell and gene therapy segment accounted for the highest revenue-grossing segment in the global plasmid DNA contract manufacturing market in 2023 owing to the rapid expansion of cell and gene therapy research and development, increasing demand for personalized medicines, and advancements in biotechnology enabling more efficient production processes. For instance, Waisman Biomanufacturing announced in December 2022 that it was expanding its plasmid DNA manufacturing plant to accommodate the growing demand for gene therapy applications. Additionally, the immunotherapy segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing prevalence of cancer and autoimmune diseases, along with the rising adoption of immunotherapy as a promising treatment modality due to its ability to harness the body's immune system to target and eradicate the disease.

By therapeutic area, the cancer segment accounted for the highest revenue-grossing segment in the global plasmid DNA contract manufacturing market in 2023 owing to the growing incidence of cancer worldwide, coupled with the development of gene-based cancer therapies and personalized treatment approaches utilizing plasmid DNA technology. For instance, Charles River Laboratories launched the eXpDNATM plasmid manufacturing platform in January 2023 to enable GMP-grade plasmid synthesis more quickly and effectively. Additionally, the infectious diseases segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing global concern over infectious disease outbreaks, the demand for rapid vaccine development, and the utilization of plasmid DNA technology in the production of vaccines for various infectious diseases.

By end-user, the pharmaceutical and biotechnology companies segment accounted for the highest revenue-grossing segment in the global plasmid DNA contract manufacturing market in 2023 owing to the increased outsourcing of plasmid DNA manufacturing activities by pharmaceutical and biotechnology companies to specialized contract manufacturers, enabling them to focus on core competencies and accelerate the development and commercialization of gene-based therapies and vaccines. For instance, in January 2023, Syngene International Limited announced the development of its viral vector production plant in Bengaluru, India, to meet the rising demand for gene therapy products. Additionally, the research institutes segment is predicted to grow at the fastest CAGR during the forecast period owing to the expanding research initiatives in gene therapy, vaccine development, and genetic engineering, driving the demand for plasmid DNA contract manufacturing services among research institutes aiming to translate scientific discoveries into clinical applications.

North American region is anticipated to have the highest revenue share during the forecast period owing to the establishment of a robust biopharmaceutical industry, strong government support for biotechnology research and development, and a favorable regulatory environment facilitating the commercialization of gene-based therapies and vaccines. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing investments in healthcare infrastructure, rising adoption of advanced biotechnologies, expanding pharmaceutical manufacturing capabilities, and a growing focus on addressing unmet medical needs, particularly in emerging economies within the region. For instance, in October 2023, LakePharma, Inc. announced the acquisition of Blue Sky BioServices, which will increase its contract manufacturing capabilities for cell and gene therapies.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Application, Therapeutic Area, and End-User
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Plasmid DNA Contract Manufacturing Market Report 2023 - 2034

Plasmid DNA Contract Manufacturing Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)

  • Cell and Gene Therapy
  • Immunotherapy
  • Others

Plasmid DNA Contract Manufacturing Market Analysis & Forecast by Therapeutic Area 2023 - 2034 (Revenue USD Bn)

  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Others

Plasmid DNA Contract Manufacturing Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Others

Plasmid DNA Contract Manufacturing Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Plasmid DNA Contract Manufacturing Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Plasmid DNA Contract Manufacturing Market: Application Estimates & Trend Analysis
7.1. Application Segment Opportunity Analysis
7.2. Cell and Gene Therapy
7.2.1. Cell and Gene Therapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Immunotherapy
7.3.1. Immunotherapy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Others
7.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Plasmid DNA Contract Manufacturing Market: Therapeutic Area Estimates & Trend Analysis
8.1. Therapeutic Area Segment Opportunity Analysis
8.2. Cancer
8.2.1. Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Infectious Diseases
8.3.1. Infectious Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Autoimmune Diseases
8.4.1. Autoimmune Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Cardiovascular Diseases
8.5.1. Cardiovascular Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.6. Others
8.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Plasmid DNA Contract Manufacturing Market: End-User Estimates & Trend Analysis
9.1. End-User Segment Opportunity Analysis
9.2. Pharmaceutical and Biotechnology Companies
9.2.1. Pharmaceutical and Biotechnology Companies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Research Institutes
9.3.1. Research Institutes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Others
9.4.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Plasmid DNA Contract Manufacturing Market
11.1. North America Plasmid DNA Contract Manufacturing Market
11.1.1. North America Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.1.4. North America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
11.1.5. North America Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Plasmid DNA Contract Manufacturing Market
11.2.1. U.S. Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Plasmid DNA Contract Manufacturing Market
11.3.1. Canada Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12. Europe Global Plasmid DNA Contract Manufacturing Market
12.1. Europe Global Plasmid DNA Contract Manufacturing Market
12.1.1. Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Plasmid DNA Contract Manufacturing Market
12.2.1. Germany Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.3. UK Global Plasmid DNA Contract Manufacturing Market
12.3.1. UK Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.3.3. UK Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
12.3.4. UK Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.4. France Global Plasmid DNA Contract Manufacturing Market
12.4.1. France Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.4.3. France Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
12.4.4. France Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Plasmid DNA Contract Manufacturing Market
12.5.1. Spain Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Plasmid DNA Contract Manufacturing Market
12.6.1. Italy Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Plasmid DNA Contract Manufacturing Market
12.7.1. Rest of Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Plasmid DNA Contract Manufacturing Market
13.1. Asia Pacific Global Plasmid DNA Contract Manufacturing Market
13.1.1. Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Plasmid DNA Contract Manufacturing Market
13.2.1. Japan Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.3. China Global Plasmid DNA Contract Manufacturing Market
13.3.1. China Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.3.3. China Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
13.3.4. China Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.4. India Global Plasmid DNA Contract Manufacturing Market
13.4.1. India Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.4.3. India Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
13.4.4. India Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Plasmid DNA Contract Manufacturing Market
13.5.1. South Korea Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Plasmid DNA Contract Manufacturing Market
13.6.1. Australia Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Plasmid DNA Contract Manufacturing Market
13.7.1. Rest of Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14. Latin America Global Plasmid DNA Contract Manufacturing Market
14.1. Latin America Global Plasmid DNA Contract Manufacturing Market
14.1.1. Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Plasmid DNA Contract Manufacturing Market
14.2.1. Brazil Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Plasmid DNA Contract Manufacturing Market
14.3.1. Mexico Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Plasmid DNA Contract Manufacturing Market
14.4.1. Argentina Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Plasmid DNA Contract Manufacturing Market
14.5.1. Rest of Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15. MEA Global Plasmid DNA Contract Manufacturing Market
15.1. MEA Global Plasmid DNA Contract Manufacturing Market
15.1.1. MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Plasmid DNA Contract Manufacturing Market
15.2.1. GCC Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Plasmid DNA Contract Manufacturing Market
15.3.1. South Africa Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Plasmid DNA Contract Manufacturing Market
15.4.1. Rest of MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, By Application, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, By Therapeutic Area, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Plasmid DNA Contract Manufacturing Market Size and Forecast, By End-User, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Aldevron
17.2. Cobra Biologics
17.3. Fujifilm Diosynth Biotechnologies
17.4. VGXI, Inc.
17.5. Waisman Biomanufacturing
17.6. LakePharma, Inc.
17.7. Richter-Helm BioLogics
17.8. PlasmidFactory GmbH & Co. KG
17.9. Nature Technology Corporation
17.10. Syngene International Limited
17.11. Cell and Gene Therapy Catapult
17.12. Eurofins Genomics
17.13. Vigene Biosciences
17.14. Kaneka Eurogentec
17.15. Genscript Biotech Corporation
18. Conclusion19. Recommendations

Companies Mentioned

  • Aldevron
  • Cobra Biologics
  • Fujifilm Diosynth Biotechnologies
  • VGXI Inc.
  • Waisman Biomanufacturing
  • LakePharma Inc.
  • Richter-Helm BioLogics
  • PlasmidFactory GmbH & Co. KG
  • Nature Technology Corporation
  • Syngene International Limited
  • Cell and Gene Therapy Catapult
  • Eurofins Genomics
  • Vigene Biosciences
  • Kaneka Eurogentec
  • Genscript Biotech Corporation.